Glenda Lassi

Glenda Lassi

Auto-generated profile, based on publicly available information

Glenda Lassi

Department of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia, Genova, Italy

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2012 in Neuron
Verified
Journal Article
Closed access
GIGiuliano Iurilli
Giuliano Iurilli
DGDiego Ghezzi
Diego Ghezzi
UUUmberto Ulcese
Umberto Ulcese
GLGlenda Lassi
Glenda Lassi
CNCristiano Nazzaro
Cristiano Nazzaro
PMPaolo Medini
Paolo Medini

13 January 2013 in Nature Neuroscience
Verified
Journal Article
Closed access
RBRiccardo Beltramo
Riccardo Beltramo
GDGiulia D'Urso
Giulia D'Urso
Marco Dal MaschioMarco Dal Maschio
Marco Dal Maschio
PFPasqualina Farisello
Pasqualina Farisello
SBSerena Bovetti
Serena Bovetti
TFTommaso Fellin
Tommaso Fellin

1 August 2006 in Cognition
Verified
Journal Article
Closed access
JFJ Franck
J Franck
GLG Lassi
G Lassi
UFU Frauenfelder
U Frauenfelder
LRL Rizzi
L Rizzi

10 March 2014 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
VTValter Tucci
Valter Tucci
TKTjitske Kleefstra
Tjitske Kleefstra
AHAndrea Hardy
Andrea Hardy
IHInes Heise
Ines Heise
SMSilvia Maggi
Silvia Maggi
PNPatrick M. Nolan
Patrick M. Nolan
The recent identification of multiple dominant mutations in the gene encoding β-catenin in both humans and mice has enabled exploration of the molecular and cellular basis of β-catenin function in cognitive impairment. In humans, β-catenin mutations that cause a spectrum of neurodevelopmental disorders have been identified. We identified de novo β-catenin mutations in patients with intellectual disability, carefully characterized their phenotypes, and were able to define a recognizable intellectual disability syndrome. In parallel, characterization of a chemically mutagenized mouse line that displays features similar to those of human patients with β-catenin mutations enabled us to investigate the consequences of β-catenin dysfunction through development and into adulthood. The mouse mutant, designated batface (Bfc), carries a Thr653Lys substitution in the C-terminal armadillo repeat of β-catenin and displayed a reduced affinity for membrane-associated cadherins. In association with this decreased cadherin interaction, we found that the mutation results in decreased intrahemispheric connections, with deficits in dendritic branching, long-term potentiation, and cognitive function. Our study provides in vivo evidence that dominant mutations in β-catenin underlie losses in its adhesion-related functions, which leads to severe consequences, including intellectual disability, childhood hypotonia, progressive spasticity of lower limbs, and abnormal craniofacial features in adults.

1 December 2016 in Trends in Neurosciences
Verified
Journal Article
Open access
GLGlenda Lassi
Glenda Lassi
ATAmy E. Taylor
Amy E. Taylor
NTNicholas J. Timpson
Nicholas J. Timpson
PKPaul J. Kenny
Paul J. Kenny
RMRobert J. Mather
Robert J. Mather
MMMarcus R. Munafò
Marcus R. Munafò
Genome-wide association studies (GWASs) have identified associations between the CHRNA5-CHRNA3-CHRNB4 gene cluster and smoking heaviness and nicotine dependence. Studies in rodents have described the anatomical localisation and function of the nicotinic acetylcholine receptors (nAChRs) formed by the subunits encoded by this gene cluster. Further investigations that complemented these studies highlighted the variability of individuals' smoking behaviours and their ability to adjust nicotine intake. GWASs of smoking-related health outcomes have also identified this signal in the CHRNA5-CHRNA3-CHRNB4 gene cluster. This insight underpins approaches to strengthen causal inference in observational data. Combining genetic and mechanistic studies of nicotine dependence and smoking heaviness may reveal novel targets for medication development. Validated targets can inform genetic therapeutic interventions for smoking cessation and tobacco-related diseases.

1 March 2016 in SLEEP
Verified
Journal Article
Closed access
GLGlenda Lassi
Glenda Lassi
LPLorenzo Priano
Lorenzo Priano
SMSilvia Maggi
Silvia Maggi
CGCelina Garcia-Garcia
Celina Garcia-Garcia
EBEdoardo Balzani
Edoardo Balzani
VTValter Tucci
Valter Tucci
S and full research articles published in SLEEP, the official journal of the APSS. Sleep and sleep disorder scientific findings.